MedCity News
AUGUST 5, 2022
On the micro level, it’s more prescriptive (i.e., regulatory best practices or good manufacturing practices). For most companies and medtech, in particular, good business practices (GBP) happens on multiple levels. On the macro level, it’s expressed as a set of ethics and principles that govern a company’s conduct.
World of DTC Marketing
MARCH 31, 2022
Under the bill proposed, Medicare beneficiaries and those insured through private plans would pay no more than $35 for a 30-day insulin prescription, or the lesser of $35 or 25% of the plan’s negotiated price for a 30-day prescription. He says that there are a limited number of manufactures in the U.S., billion to $5.7
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JULY 15, 2022
Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. In-house manufacturing the norm.
World of DTC Marketing
APRIL 12, 2021
Pharmaceutical manufacturers and distributors work together in a robust system to deliver high-quality products, but drug manufacturing and distribution have become increasingly complex in recent years. The answer lies in both an outdated way we develop prescription drugs and the continued quest for the next big blockbuster.
pharmaphorum
DECEMBER 29, 2022
The turbulence of the last three years can make it seem as though pharma manufacturers have been operating in an atmosphere of non-stop crisis. The net effect has been to stimulate change in every aspect of the pharma industry – an industry not exactly known for its embrace of manufacturing innovation.
World of DTC Marketing
OCTOBER 21, 2021
More than $170 million of this spending was for products voluntarily withdrawn by their manufacturers after clinical trials showed that they did not improve overall survival in people with various types of cancer.
pharmaphorum
JANUARY 6, 2023
In 2023, expect manufacturers to further shift their focus away from acquiring new patient prescriptions to retaining existing customers. The account carried an official blue check mark, but in fact it did not belong to the prescription drugmaker. in 1979 to 2.8%in Ensuring patient access.
Expert insights. Personalized for you.
314 
Let's personalize your content